Skip to main content
OpenTrials

Clinical trial condition

Mouth Neoplasms

Explore clinical trials studying Mouth Neoplasms. Study availability and eligibility vary by location and protocol.

250 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Mouth Neoplasms trial results

Active, not recruiting

Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers

NCT04209660

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +12 more
Locations
  • Baptist Alliance MCI Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Active, not recruiting

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

NCT05608876

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations
  • The Kinghorn Cancer Centre Sydney, New South Wales, Australia
  • Metro South Hospital and Health Service, via the Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Cardiff and Vale University Health Board - University Hospital of Wales (UHW) Cardiff, United Kingdom
  • East and North Hertfordshire NHS Trust (Incorporating Mount Vernon Cancer Centre) of Lister Hospital Stevenage, Hertfordshire, United Kingdom
View Trial Details
Completed

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

NCT02576431

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +43 more
Locations
  • Stanford Cancer Center Palo Alto Palo Alto, California, United States
  • UCLA Health Santa Monica Cancer Care Santa Monica, California, United States
  • Memorial Cancer Institute at West Pembroke Pines, Florida, United States
  • The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
View all 98 locations
View Trial Details
Completed

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

NCT02254278

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 222 locations
View Trial Details

Related conditions